awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35546759-1CB33DE5-4078-4DB6-BC6B-ACAB1F6D7329
Q35546759-1CB33DE5-4078-4DB6-BC6B-ACAB1F6D7329
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35546759-1CB33DE5-4078-4DB6-BC6B-ACAB1F6D7329
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.
P2860
Q35546759-1CB33DE5-4078-4DB6-BC6B-ACAB1F6D7329
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35546759-1CB33DE5-4078-4DB6-BC6B-ACAB1F6D7329
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4cc9e96f76e3ecce9f9c5f7b012bc907d6891a3a
P2860
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.